TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1]
C(3〜6か月)
Backcross to C57BL/6 (Heterozygote x C57BL/6J)Homozygous deficient mice are viable and fertile.
宮島 篤
Backcross to C57BL/6 (Heterozygote x C57BL/6J) Homozygous deficient mice are viable and fertile.
<a href='https://brc.riken.jp/mus/pcr01491'>Genotyping protocol -PCR-</a>
B6.Cg-Lrrn4<tm1Ami>/Rbrc
開発年:2001年 開発者:坂東高功先生、宮島篤先生 機関名:東京大学、分子細胞生物学研究所
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Mol. Cell Biol., 10, 4160-4175 (2005).The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR.
Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="https://www.iqb.u-tokyo.ac.jp/cytokine/" target="_blank">Lab HP (Japanese)</A>
繁殖効率:A 行動の異常がある
true
条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Mol. Cell Biol., 10, 4160-4175 (2005).<br>寄託者の承諾を得る。
開発年:2001年開発者:坂東高功先生、宮島篤先生機関名:東京大学、分子細胞生物学研究所
RBRC01491
Atsushi MIYAJIMA
B6;B6CB-Lrrn4<tm1>/Rbrc
NLRR4-KO(B6); B6.Cg-B430119L13Rik<tm>
NLRR4-KO(B6); B6.Cg-B430119L13Rik<tm>
mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, E. coli lacZ, poly A, mouse Lrrn4 genomic DNA
Univ. Tokyo
繁殖効率:A行動の異常がある
C (3-6 months)
国立大学法人東京大学
Developed by Drs. Takayoshi Bando and Atsushi Miyajima at the University of Tokyo in 2001. The TT2 ES cells originated from an F1 embryo between C57BL/6 and CBA mice were used. The targeting construct contains relpaced exons with the beta-galactosidase and the neomycin resistance genes by homologous reconbination. The NLRR4 deficient mice were backcrossed to C57BL/6JJcl.
NLRR4-KO(B6); B6.Cg-B430119L13Rik<tm>, B6;B6CB-Lrrn4<tm1>/Rbrc
NLRR4-KO(B6); B6.Cg-B430119L13Rik<tm>, B6;B6CB-Lrrn4<tm1>/Rbrc
B6.Cg-B430119L13Rik<tm>. NLRR4 is a member of the neuronal leucine-rich repeat protein family. NLRR proteins are type I transmembrane proteins with leucine-rich repeats and a fibronectine type III repeat, and expressed in neuronal tissues. NLRR4 deficient mice have a severe damage to their long-term memory in hippocampus-dependent tasks, while their hippocampal long-term potentiation was intact. NLRR4 plays a role in hippocamus-dependent long-lasting memory.